Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (131-140 of 287) with videos related to

Pageof 29
Sort By:
Inflammatory Bowel Diseases|November 2, 2007
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitisMarc Ferrante, Sarah Declerck, Gert De Hertogh, et al.
Inflammatory Bowel Diseases|March 23, 2013
Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitisBart Lemmens, Ingrid Arijs, Gert Van Assche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2017
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of InfliximabLieven Pouillon, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|January 13, 2017
Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel DiseaseSofie Coenen, Ellen Weyts, Cedric Jorissen, et al.
Inflammatory Bowel Diseases|June 1, 2012
Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitisClémentine Perrier, Gert de Hertogh, Jonathan Cremer, et al.
The American Journal of Gastroenterology|August 23, 2002
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's diseasePeter Suenaert, Veerle Bulteel, Liesbeth Lemmens, et al.
Gastroenterology|July 10, 2003
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort studySeverine Vermeire, Maja Noman, Gert Van Assche, et al.
Journal of Crohn'S & Colitis|October 18, 2018
Vedolizumab in Refractory Microscopic Colitis: An International Case SeriesPauline Rivière, Andreas Münch, Pierre Michetti, et al.
Journal of Crohn'S & Colitis|April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patientsFilip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Scandinavian Journal of Gastroenterology|March 18, 2020
Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapySofie Coenen, Egon Nijns, Ellen Weyts, et al.
Pageof 29

Showing results (131-140 of 287) with videos related to

Sort By:
Pageof 29
Inflammatory Bowel Diseases|November 2, 2007
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitisMarc Ferrante, Sarah Declerck, Gert De Hertogh, et al.
Inflammatory Bowel Diseases|March 23, 2013
Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitisBart Lemmens, Ingrid Arijs, Gert Van Assche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2017
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of InfliximabLieven Pouillon, Marc Ferrante, Gert Van Assche, et al.
Inflammatory Bowel Diseases|January 13, 2017
Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel DiseaseSofie Coenen, Ellen Weyts, Cedric Jorissen, et al.
Inflammatory Bowel Diseases|June 1, 2012
Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitisClémentine Perrier, Gert de Hertogh, Jonathan Cremer, et al.
The American Journal of Gastroenterology|August 23, 2002
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's diseasePeter Suenaert, Veerle Bulteel, Liesbeth Lemmens, et al.
Gastroenterology|July 10, 2003
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort studySeverine Vermeire, Maja Noman, Gert Van Assche, et al.
Journal of Crohn'S & Colitis|October 18, 2018
Vedolizumab in Refractory Microscopic Colitis: An International Case SeriesPauline Rivière, Andreas Münch, Pierre Michetti, et al.
Journal of Crohn'S & Colitis|April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patientsFilip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Scandinavian Journal of Gastroenterology|March 18, 2020
Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapySofie Coenen, Egon Nijns, Ellen Weyts, et al.
Pageof 29